Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257 (Q36320322)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257 |
scientific article |
Statements
1 reference
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257 (English)
1 reference
Grace A McComsey
1 reference
Daniel R Kuritzkes
1 reference
Ighovwerha Ofotokun
1 reference
Lumine H Na
1 reference
Raphael J Landovitz
1 reference
Heather J Ribaudo
1 reference
Catherine Godfrey
1 reference
Francesca Aweeka
1 reference
Susan E Cohn
1 reference
Manish Sagar
1 reference
Todd T Brown
1 reference
Kristine B Patterson
1 reference
Michael F Para
1 reference
Randi Y Leavitt
1 reference
Angelina Villasis-Keever
1 reference
Bryan P Baugh
1 reference
Jeffrey L Lennox
1 reference
Judith S Currier
1 reference
AIDS Clinical Trials Group (ACTG) A5257 Team
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference